Hast, B. E., Cloer, E. W., Goldfarb, D., Li, H., Siesser, P. F., Yan, F., . . . Major, M. B. (2013). Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination.
استشهاد بنمط شيكاغوHast, Bridgid E., et al. Cancer-derived Mutations in KEAP1 Impair NRF2 Degradation but Not Ubiquitination. 2013.
MLA استشهادHast, Bridgid E., et al. Cancer-derived Mutations in KEAP1 Impair NRF2 Degradation but Not Ubiquitination. 2013.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.